Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
Författare
Summary, in English
Prediction of radiographic progression (RP) in early rheumatoid arthritis (eRA) would be very useful for optimal choice among available therapies. We evaluated a multi-biomarker disease activity (MBDA) score, based on 12 serum biomarkers as a baseline predictor for 1-year RP in eRA.
Avdelning/ar
Publiceringsår
2015
Språk
Engelska
Sidor
1102-1109
Publikation/Tidskrift/Serie
Annals of the Rheumatic Diseases
Volym
74
Issue
6
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
BMJ Publishing Group
Ämne
- Rheumatology and Autoimmunity
Status
Published
ISBN/ISSN/Övrigt
- ISSN: 1468-2060